We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

167 hedge funds and large institutions have $1.41B invested in Array Biopharma Inc in 2016 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 62 increasing their positions, 42 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more call options, than puts

Call options by funds: $12.7M | Put options by funds: $7.38M

48% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 42

41% more capital invested

Capital invested by funds: $1B → $1.41B (+$407M)

20% more funds holding in top 10

Funds holding in top 10: 5 → 6 (+1)

0% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 35

1% less funds holding

Funds holding: 169 → 167 (-2)

Holders
167
Holders Change
-2
Holders Change %
-1.18%
% of All Funds
4.17%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.15%
New
35
Increased
62
Reduced
42
Closed
35
Calls
$12.7M
Puts
$7.38M
Net Calls
+$5.28M
Net Calls Change
+$7.93M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$21.3M
2
CCM
Consonance Capital Management
New York
+$20M
3
EAM
EverPoint Asset Management
Connecticut
+$18.4M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$17.7M
5
O
OrbiMed
New York
+$14M

Top Sellers

Rank Fund Capital Flow
1
SCM
Sarissa Capital Management
Connecticut
-$29M
2
Millennium Management
Millennium Management
New York
-$26.8M
3
AG
Artal Group
Luxembourg
-$16.6M
4
BI
BVF Inc
California
-$10.9M
5
Citadel Advisors
Citadel Advisors
Florida
-$6.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
51
Wells Fargo
California
$3.31M +$955K +129,846 +53%
GAMA
52
Graticule Asia Macro Advisors
New York
$3.21M +$2.69M +365,000 New
California State Teachers Retirement System (CalSTRS)
53
California State Teachers Retirement System (CalSTRS)
California
$3.03M +$288K +39,200 +13%
Macquarie Group
54
Macquarie Group
Australia
$2.9M – – –
GC
55
Guggenheim Capital
Illinois
$2.36M +$1.97M +268,178 New
State of New Jersey Common Pension Fund D
56
State of New Jersey Common Pension Fund D
New Jersey
$2.33M – – –
SIM
57
Spark Investment Management
New York
$2.31M -$4.53M -615,100 -70%
California Public Employees Retirement System
58
California Public Employees Retirement System
California
$2.16M -$243K -33,000 -12%
Swiss National Bank
59
Swiss National Bank
Switzerland
$2.13M -$102K -13,900 -5%
AllianceBernstein
60
AllianceBernstein
Tennessee
$1.99M +$203K +27,600 +14%
PI
61
Putnam Investments
Massachusetts
$1.98M +$669K +90,922 +67%
KIA
62
Kopp Investment Advisors
Minnesota
$1.93M -$805K -109,356 -33%
JP Morgan Chase
63
JP Morgan Chase
New York
$1.85M -$51K -6,933 -3%
PNC Financial Services Group
64
PNC Financial Services Group
Pennsylvania
$1.8M +$1.5M +203,570 +15,659%
RhumbLine Advisers
65
RhumbLine Advisers
Massachusetts
$1.77M +$157K +21,372 +12%
BC
66
Boxer Capital
California
$1.76M – – –
ACM
67
Atika Capital Management
New York
$1.67M +$464K +63,000 +50%
Nisa Investment Advisors
68
Nisa Investment Advisors
Missouri
$1.61M +$428K +58,200 +47%
Handelsbanken Fonder
69
Handelsbanken Fonder
Sweden
$1.58M +$368K +50,000 +38%
AIM
70
Alambic Investment Management
California
$1.52M -$132K -17,900 -9%
UBS Group
71
UBS Group
Switzerland
$1.47M +$1.02M +138,635 +480%
New York State Common Retirement Fund
72
New York State Common Retirement Fund
New York
$1.45M +$231K +31,400 +24%
ACA
73
Avoro Capital Advisors
New York
$1.41M +$1.18M +160,000 New
PVI
74
Pura Vida Investments
New York
$1.38M +$937K +127,360 +425%
CS
75
Credit Suisse
Switzerland
$1.28M -$128K -17,373 -11%
1 2
3
4 5

ARRY Hedge Fund Activity: Q4 2016 in Review

167 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q4 2016, worth a combined $1.41B — up 41% from $1B a quarter earlier.

Fund positioning in ARRY was balanced in Q4 2016: 35 funds opened new positions, 35 closed out, 62 added to existing stakes and 42 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $21.3M. The largest seller was Sarissa Capital Management, exiting entirely with an estimated $29M sold.

  • 167 institutional investors held Array Biopharma Inc (ARRY) as of Q4 2016, down from 169 in Q3 2016.
  • Funds reported $1.41B of Array Biopharma Inc stock for Q4 2016, up 41% quarter-over-quarter.
  • 35 funds opened new Array Biopharma Inc positions in Q4 2016 and 35 closed out, a net change of 0 holders.
  • The largest Array Biopharma Inc buyer in Q4 2016 was Morgan Stanley, an estimated $21.3M added.
  • The largest Array Biopharma Inc seller in Q4 2016 was Sarissa Capital Management, an estimated $29M sold.

Based on aggregated 13F filings for Q4 2016.